诱导中度DNA损伤增强了巨核形成和血小板生产
Roelof H Bekendam1,2,3, Virginia Camacho1,2, Andrew P Stone1,2,4
1Vascular Biology Program, Boston Children's Hospital, Boston, Massachusetts.
bioRxiv : the preprint server for biology
|June 4, 2025
概括
聚ADP核糖聚合酶 (PARP) 抑制剂可能导致血小板数量低下. 然而,低剂量PARP抑制或中等程度的DNA损伤令人惊地增强了巨核形成,增加了血小板的产生.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 聚ADP рибо酶聚合酶 (PARP) 抑制剂用于癌症治疗.
- 一个已知的副作用是血小板缺血 (血小板数量低),可能与巨核细胞 (MKs) 相关.
- 对DNA损伤和修复抑制对大核细胞形成的影响尚不清楚.
研究的目的:
- 为了研究 PARP 抑制剂对大核形成和血小板生成的影响.
- 探索DNA损伤和血小板计数之间的关系.
主要方法:
- 小鼠接受了PARP抑制剂 (尼拉帕里布,奥拉帕里布) 或马辐射治疗.
- 评估了巨核细胞和血小板的数量.
- 使用γH2AX和彗星分析测量了MK和祖先的DNA损伤.
- 评估了血小板功能.
主要成果:
- 高剂量的尼拉帕里布在小鼠中引起了血小板缺血.
- 较低剂量的尼拉帕里布显著增加了MK和血小板数量 (>1.5倍).
- 增加的MKs和血小板与MKs和祖先的DNA损伤高相关.
- 马辐射也增加了MK和血小板计数.
- 来自接受治疗的小鼠的血小板显示正常功能.
结论:
- 通过低剂量PARP抑制剂或辐射诱导的中度DNA损伤,增强了巨核形成并增加了血小板的产生.
- 这揭示了一个新的机制,将DNA损伤与血小板生成联系起来.
- 准DNA损伤途径可能是刺激活体血小板生产的策略.
更多相关视频
06:57Leukodepletion Filters-Derived CD34+ Cells As a Cell Source to Study Megakaryocyte Differentiation and Platelet Formation
Published on: May 20, 2021
4.5K
14:30Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
Published on: August 7, 2021
7.5K
相关概念视频
Structure and Function of Platelets
3.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.0K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
DNA Damage can Stall the Cell Cycle
10.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.0K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
